Orit Gefen

4.6k total citations · 3 hit papers
16 papers, 3.1k citations indexed

About

Orit Gefen is a scholar working on Genetics, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Orit Gefen has authored 16 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Molecular Biology and 4 papers in Molecular Medicine. Recurrent topics in Orit Gefen's work include Evolution and Genetic Dynamics (9 papers), Bacterial Genetics and Biotechnology (7 papers) and Gene Regulatory Network Analysis (4 papers). Orit Gefen is often cited by papers focused on Evolution and Genetic Dynamics (9 papers), Bacterial Genetics and Biotechnology (7 papers) and Gene Regulatory Network Analysis (4 papers). Orit Gefen collaborates with scholars based in Israel, United States and China. Orit Gefen's co-authors include Nathalie Q. Balaban, Ofer Fridman, Irine Ronin, Asher Brauner, Irit Levin-Reisman, Noam Shoresh, Maskit Bar‐Meir, Jiafeng Liu, Jacob Strahilevitz and Chana Gabay and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Orit Gefen

13 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distinguishing between resistance, tolerance and persistence to antibiotic treatment

2016 1.1k citations Asher Brauner, Ofer Fridman et al. Nature Reviews Microbiology profile →
Antibiotic tolerance facilitates the evolution of resistance

2017 874 citations Irit Levin-Reisman, Irine Ronin et al. Science profile →
Effect of tolerance on the evolution of antibiotic resistance under drug combinations

2020 331 citations Jiafeng Liu, Orit Gefen et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Orit Gefen Israel	12	1.5k	1.1k	1.0k	551	400	16	3.1k
Irine Ronin Israel	12	1.3k 0.9×	874 0.8×	1.1k 1.1×	375 0.7×	430 1.1×	14	2.6k
Maarten Fauvart Belgium	30	2.2k 1.4×	1.1k 1.1×	1.4k 1.4×	418 0.8×	712 1.8×	81	4.2k
Amy L. Spoering United States	15	2.1k 1.3×	869 0.8×	1.0k 1.0×	479 0.9×	518 1.3×	17	3.3k
Michael A. Lobritz United States	24	1.8k 1.2×	1.1k 1.1×	730 0.7×	1.2k 2.1×	272 0.7×	32	4.3k
Mario Juhas Switzerland	32	2.4k 1.6×	757 0.7×	722 0.7×	347 0.6×	502 1.3×	53	3.8k
Geoffrey A. McKay Canada	24	1.6k 1.0×	918 0.9×	527 0.5×	660 1.2×	307 0.8×	50	2.7k
Iris Keren United States	11	1.5k 0.9×	937 0.9×	1.0k 1.0×	746 1.4×	482 1.2×	11	2.8k
Mark P. Brynildsen United States	26	2.7k 1.7×	1.2k 1.2×	1.5k 1.5×	420 0.8×	714 1.8×	69	4.3k
Remy Chait United States	17	2.6k 1.7×	1.2k 1.1×	2.3k 2.2×	468 0.8×	407 1.0×	22	4.8k
Henrietta Venter Australia	31	1.4k 0.9×	1.3k 1.3×	437 0.4×	395 0.7×	253 0.6×	104	3.4k

Countries citing papers authored by Orit Gefen

Since Specialization

Citations

This map shows the geographic impact of Orit Gefen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orit Gefen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orit Gefen more than expected).

Fields of papers citing papers by Orit Gefen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orit Gefen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orit Gefen. The network helps show where Orit Gefen may publish in the future.

Co-authorship network of co-authors of Orit Gefen

This figure shows the co-authorship network connecting the top 25 collaborators of Orit Gefen. A scholar is included among the top collaborators of Orit Gefen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orit Gefen. Orit Gefen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Gefen, Orit, et al.. (2026). Differentiation between regulated and disrupted growth arrests allows tailoring of effective treatments for antibiotic persistence. Science Advances. 12(1). eadt6577–eadt6577. 1 indexed citations

Landman, David, Orit Gefen, Ayelet Michael-Gayego, et al.. (2025). Bactericidal activity of antibiotic combinations against clinical isolates of Enterococcus gallinarum and Enterococcus casseliflavus. Journal of Antimicrobial Chemotherapy. 80(6). 1519–1525.

Gefen, Orit, et al.. (2025). Uncovering phenotypic inheritance from single cells with Microcolony-seq. Cell. 188(19). 5313–5331.e18.

Gefen, Orit, Ronen Fluss, Irit Levin-Reisman, et al.. (2022). Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study. Clinical Infectious Diseases. 75(10). 1706–1713. 15 indexed citations

Liu, Jiafeng, Orit Gefen, Ziyin Zhang, et al.. (2022). Interaction Tolerance Detection Test for Understanding the Killing Efficacy of Directional Antibiotic Combinations. mBio. 13(1). e0000422–e0000422. 9 indexed citations

Levin-Reisman, Irit, et al.. (2021). Observation of universal ageing dynamics in antibiotic persistence. Nature. 600(7888). 290–294. 57 indexed citations

Liu, Jiafeng, Orit Gefen, Irine Ronin, Maskit Bar‐Meir, & Nathalie Q. Balaban. (2020). Effect of tolerance on the evolution of antibiotic resistance under drug combinations. Science. 367(6474). 200–204. 331 indexed citations breakdown →

Levin-Reisman, Irit, et al.. (2017). Antibiotic tolerance facilitates the evolution of resistance. Science. 355(6327). 826–830. 874 indexed citations breakdown →

Gefen, Orit, et al.. (2017). TDtest: easy detection of bacterial tolerance and persistence in clinical isolates by a modified disk-diffusion assay. Scientific Reports. 7(1). 41284–41284. 101 indexed citations

10.

Brauner, Asher, Ofer Fridman, Orit Gefen, & Nathalie Q. Balaban. (2016). Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nature Reviews Microbiology. 14(5). 320–330. 1054 indexed citations breakdown →

11.

Mizrahi, Sivan Pearl, Orit Gefen, Itamar Simon, & Nathalie Q. Balaban. (2016). Persistence to anti-cancer treatments in the stationary to proliferating transition. Cell Cycle. 15(24). 3442–3453. 28 indexed citations

12.

Gefen, Orit, Ofer Fridman, Irine Ronin, & Nathalie Q. Balaban. (2013). Direct observation of single stationary-phase bacteria reveals a surprisingly long period of constant protein production activity. Proceedings of the National Academy of Sciences. 111(1). 556–561. 143 indexed citations

13.

Levin-Reisman, Irit, Orit Gefen, Ofer Fridman, et al.. (2010). Automated imaging with ScanLag reveals previously undetectable bacterial growth phenotypes. Nature Methods. 7(9). 737–739. 122 indexed citations

14.

Gefen, Orit & Nathalie Q. Balaban. (2009). The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiology Reviews. 33(4). 704–717. 240 indexed citations

15.

Gefen, Orit & Nathalie Q. Balaban. (2008). The Moore's Law of microbiology – towards bacterial culture miniaturization with the micro-Petri chip. Trends in biotechnology. 26(7). 345–347. 19 indexed citations

16.

Gefen, Orit, et al.. (2008). Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proceedings of the National Academy of Sciences. 105(16). 6145–6149. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact